| |
@Last Software
GlycoFi
Icovia
M2S
Scribe |
GlycoFi, Inc. is revolutionizing how the biopharmaceutical industry produces biotherapeutics. GlycoFi's fungal protein expression platform produces fully humanized glycoproteins of unprecedented homogeneity in a fraction of the time and cost using a chemically defined medium. |
GlycoFi was acquired by Merck in June 2006.
www.glycofi.com |
|